Merck Other Long-Term Assets 2010-2024 | MRK

Merck other long-term assets for the quarter ending June 30, 2024 were $12.702B, a 24.69% increase year-over-year.

  • Merck other long-term assets for 2023 were $11.996B, a 25.9% increase from 2022.
  • Merck other long-term assets for 2022 were $9.528B, a 17.73% decline from 2021.
  • Merck other long-term assets for 2021 were $11.582B, a 17.21% increase from 2020.

Merck Other Long-Term Assets 2010-2024 | MRK

  • Merck other long-term assets for 2023 were $11.996B, a 25.9% increase from 2022.
  • Merck other long-term assets for 2022 were $9.528B, a 17.73% decline from 2021.
  • Merck other long-term assets for 2021 were $11.582B, a 17.21% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B